|Bid||0.0500 x N/A|
|Ask||0.0600 x N/A|
|Day's Range||0.0600 - 0.0600|
|52 Week Range||0.0350 - 0.1850|
|Beta (5Y Monthly)||1.87|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Each of the units is comprised of one common share and one common share purchase warrant. Each whole warrant will entitle the holder to acquire one additional common share of Fieldex at a price of $0.08 until March 20, 2022. Fieldex will use the proceeds from the closing of the private placement for working capital purposes.
In addition, Fieldex has relinquished its interest in the mining claims comprising the Lac Sairs property in favour of one creditor in settlement of a debt in an amount of $10,250 , which debt resulted from exploration services. The Insider Debt Settlement is considered a "related party transaction" as defined under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101").
ROUYN-NORANDA, QC , Jan. 14, 2020 /CNW Telbec/ - Fieldex Exploration Inc. (FLX.V) (F7E1.F) is pleased to announce that its common shares resumed trading at the opening of business on January 14 , 2020. Fieldex's shares are listed for trading on the as a Tier 2 issuer on the TSX Venture Exchange under the trading symbol "FLX". Fieldex is also pleased to announce that its Board of Directors has appointed Mr. Mr. Pierre Vézina to Fieldex's Board of Directors.
ROUYN-NORANDA, QC, Nov. 29, 2019 /CNW Telbec/ - Fieldex Exploration Inc. (TSXV:FLX.V - News) (Frankfurt:F7E1.F - News) announces the termination of the Business Combination Agreement dated May 24, 2019, as amended, between Fieldex and Copeland Biosciences Corp. ("Copeland Biosciences") and of the Amalgamation Agreement dated as of May 24, 2019, as amended, among Fieldex, Copeland Biosciences and 1209908 B.C. Ltd., a wholly-owned subsidiary of Fieldex incorporated for the purposes of completing the proposed reverse take-over of Fieldex by Copeland Biosciences (the "Reverse Take-over"). As a result of the termination of the two agreements, Fieldex will not proceed with the Reverse Take-over. Fieldex will focus on finding other opportunities to increase shareholder value.
ROUYN-NORANDA, QC, Aug. 6, 2019 /CNW Telbec/ - Fieldex Exploration Inc. ("Fieldex") (TSXV:FLX.V - News) (Frankfurt:F7E1.F - News) is pleased to announce that at an annual and special meeting of shareholders held yesterday (the "Meeting"), Fieldex's shareholders elected Martin Dallaire, Donald Lacasse and Jean-Pierre Landry, as directors of Fieldex. Following the Meeting, Fieldex's Board of Directors re-appointed Martin Dallaire as President and Chief Executive Officer and Donald Lacasse as Chief Financial Officer and Secretary of Fieldex.